Freedom Investment Management, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$200,000
-10.3%
6,198
-14.3%
0.02%
+5.9%
Q2 2021$223,000
+10.4%
7,230
-6.4%
0.02%
+6.2%
Q1 2021$202,000
-46.3%
7,727
-28.0%
0.02%
-46.7%
Q1 2019$376,000
+36.7%
10,735
+71.3%
0.03%
+76.5%
Q3 2018$275,000
-69.1%
6,266
-57.8%
0.02%
-68.5%
Q2 2018$890,000
+256.0%
14,863
+172.7%
0.05%
+315.4%
Q1 2018$250,000
-32.6%
5,451
-36.7%
0.01%
-38.1%
Q2 2017$371,0008,6070.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders